← Back to Clinical Trials
Recruiting NCT07181876

NCT07181876 Robotic Minimally Invasive Inguinal Hernia Repair Post-Market Clinical Study With the DEXTER Robotic System

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07181876
Status Recruiting
Phase
Sponsor Distalmotion SA
Condition Inguinal Hernia Repair
Study Type OBSERVATIONAL
Enrollment 140 participants
Start Date 2025-11-26
Primary Completion 2028-12

Eligibility & Interventions

Sex All sexes
Min Age 22 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
inguinal hernia repair

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 140 participants in total. It began in 2025-11-26 with a primary completion date of 2028-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this post-market, observational study is to collect data under anticipated conditions of use that demonstrates that DEXTER performs as intended in the intended patient population, including a variety of representative disease etiologies and demographic groups.

Eligibility Criteria

Inclusion Criteria: * Subject is ≥ 22 years of age at time of enrollment/consent * Subject is indicated for and planned to undergo robot-assisted and laparoscopic surgery for unilateral or bilateral inguinal hernia repair * Subject is able and willing to comply with the protocol requirements, has been informed of the nature of the study, and has signed the IRB-approved informed consent form Exclusion Criteria: * Subject with any relative and absolute contraindications for the use of conventional endoscopes and endoscopic surgical instruments and/or general non-procedure specific contraindications to endoscopic surgery including bleeding diathesis and pregnancy * Subject is participating in another clinical investigation at the time of enrollment or planned participation at any time during this clinical study * Subject has a known or suspected medical condition that, in the opinion of the Investigator, may put the subject at risk for participation in this clinical study

Contact & Investigator

Central Contact

Pascal Lehmann

✉ pascal.lehmann@distalmotion.com

📞 +41215105890

Frequently Asked Questions

Who can join the NCT07181876 clinical trial?

This trial is open to participants of all sexes, aged 22 Years or older, studying Inguinal Hernia Repair. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07181876 currently recruiting?

Yes, NCT07181876 is actively recruiting participants. Contact the research team at pascal.lehmann@distalmotion.com for enrollment information.

Where is the NCT07181876 trial being conducted?

This trial is being conducted at Buffalo, United States, Houston, United States.

Who is sponsoring the NCT07181876 clinical trial?

NCT07181876 is sponsored by Distalmotion SA. The trial plans to enroll 140 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology